Ye Fu, PhD profile page

Dr. Ye Fu, is co-founder and chief scientific officer at Stellaromics, where he leads the development of next-generation spatial biology technologies. He has a multidisciplinary research background spanning biochemistry, biophysics, structural biology and genomics. Dr. Fu earned his PhD in chemistry from the University of Chicago under Prof. Chuan He, and finished postdoctoral training with Prof. Xiaowei Zhuang at Harvard University. His doctoral research helped establish the field of reversible RNA methylation, laying the groundwork for discoveries recognized by the 2023 Wolf Prize in Chemistry. Dr. Fu is an inventor on multiple patents and has authored numerous high-impact publications, including first-author papers in Cell and Nature Chemical Biology, with his work cited more than 25,000 times. He previously served as principal at Plaisance Capital Management, where he helped incubate and grow several biotechnology companies, and continues to advise early- and mid-stage biotech ventures.